Chapel Hill

Cempra gets $10M milestone for its antibiotic development in Japan

North Carolina antibiotics maker Cempra has received a $10 million milestone payment from a Japanese drugmaker – indicative of the country’s need for a next-gen antibiotic. Toyama Pharmaceutical, a subsidiary of Fujifilm Holdings, owns exclusive rights to develop and commercialize Cempra’s new antibiotic, solithromycin, in Japan for respiratory tract infections like pneumonia. Though U.S. usage is number […]

Devices & Diagnostics

Applying neuromodulation to acute heart failure nets NC device startup a $13M series A

Neurostimulation devices that send mild electrical pulses to target nerves are arguably the fastest-growing segment of the medical devices sector. They’re primarily being commercialized in neurology and urology but are apparently showing promise in cardiology too. A startup called NeuroTronik spun out of medical device incubator Synecor last year says it’s raised a $13.1 million […]

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.